Characteristic | Usual care group | PP intervention group | ITT intervention group |
---|---|---|---|
General practices | |||
No. of general practices | 23 | 23 | 23 |
Years of working experience (as GP) of GP – median (range) | 14 (4-36) | 21 (1-36) | 21 (1-36) |
Participants | |||
No. of participants | 575 | 319 | 492 |
Caucasian – no. (%) | 543 (94.4) | 297 (93.1) | 451 (91.7) |
Higher education – no. (%)b | 168 (29.2) | 124 (38.9)c | 180 (36.6)c |
10-year CVD risk score for inclusion (%)d | 7.0 (± 5.6) | 6.5 (± 4.8) | 6.7 (± 4.2) |
Cardiovascular risk factors | |||
10-year CVD risk score (%)e | 5.1 (± 3.7) | 4.7 (± 4.0) | 4.9 (± 3.7) |
Age (years) | 54.9 (± 9.2) | 54.5 (± 8.0) | 54.5 (± 7.8) |
Female – no. (%) | 420 (73.0) | 229 (71.8) | 347 (70.5) |
Smokers – no. (%) | 66 (11.5) | 19 (6.0)c | 38 (7.7)c |
Systolic blood pressure (mmHg) | 139.8 (± 16.3) | 140.4 (± 17.2) | 140.9 (± 20.8) |
Total cholesterol/HDL-cholesterol ratio | 3.7 (± 1.4) | 3.7 (± 1.0) | 3.8 (± 1.0) |
LDL cholesterol (mg/dl) | 126.8 (± 55.1) | 126.4 (± 38.8) | 127.2 (± 42.5) |
Medication use at baseline | |||
Using antihypertensive drugs – no. (%) | 479 (83.3) | 280 (87.8) | 431 (87.6) |
Agents acting on the renin-angiotensin system – no. (%) | 300 (52.2) | 163 (51.1) | 276 (56.1) |
Diuretics – no. (%) | 267 (46.4) | 136 (42.6) | 216 (43.9) |
Beta-blocking agents – no. (%) | 154 (26.8) | 83 (26.0) | 125 (25.4) |
Calcium channel blockers – no. (%) | 62 (10.8) | 37 (11.6) | 61 (12.4) |
Other antihypertensive drugs – no. (%) | 3 (0.5) | 1 (0.3) | 2 (0.5) |
Using antihypertensive drugs from ≥ 2 classes – no. (%) | 58 (10.1) | 20 (6.3)c | 44 (8.9) |
Using lipid-lowering drugs – no. (%) | 163 (28.3) | 65 (20.4)c | 105 (21.3) |
HMG CoA reductase inhibitors – no. (%) | 162 (28.2) | 62 (19.4)c | 101 (20.5)c |
Other lipid-lowering drugs – no. (%) | 10 (2.0) | 8 (2.5) | 11 (2.2) |
Using both antihypertensive and lipid-lowering drugs – no. (%) | 67 (11.7) | 27 (8.5)c | 44 (8.9)c |